Bioxonics, which develops in vitro diagnostic devices based on technological prowess, is a company that was founded through the Ministry of Science and ICT’s ‘Startup Support Project for Researchers from Bio-Companies.’
Alzheimer's disease is a common symptom in an aging society. Unfortunately, because there is no cure for Alzheimer's yet, the best way to diagnose it as soon as possible and delay its exacerbation through medication (recommended by the World Alzheimer's Association). Because these drug delays become more effective at an earlier stage of diagnosis, Bioxonics believes it is worthwhile to have an in vitro diagnostic device that can diagnose Alzheimer's mildly or before, allowing many people to easily get an early diagnosis of Alzheimer's so that they can protect not only an individual's life but also a family's life from Alzheimer's.
By expanding the diagnostic area of Alzheimer's/hard perception by applying high-tech high-sensitivity semiconductor sensors and diagnostic algorithms, we will provide cardiovascular diseases, diabetes diseases, and even viral infections so that we can enjoy a better life. Thank you.
BIOXONICS CEO